
Medical Device R&D Manufacturer, Distributor
Step upEmpower the Local Medical Innovation Ecosystem
Shanghai and HangzhouJuly 21, 2023PR Newswire -- July 19, 2023, BD Medical Greater China Innovation Center grandly opened in Gongshu District, Hangzhou City, Zhejiang Province. Sun Xudong, Deputy Mayor of Hangzhou Municipal People's Government, Hu Zhenfang, Deputy Director of Zhejiang Provincial Department of Commerce, Li Zhilong, Secretary of Gongshu District Committee of Hangzhou, Tom Polen, Chairman of the Board, CEO and President of BD Medical, Deng Jianmin, Senior Vice President of BD Medical Global and General Manager of Greater China, and other leaders and guests jointly witnessed this important moment. AsBD's First Digital and Intelligent Comprehensive Innovation Center, BD Medical Greater China Innovation Center will build a comprehensive capability center and innovation hub with professional and cutting-edge digital intelligence innovation base, world-leading laboratory facilities, upgraded customer experience, and multifunctional training and event incubation spaces to empower the construction of a local innovative medical ecosystem.

BD Medical's First Digital and Intelligent Comprehensive Innovation Center in China Grandly Opens
Build an Innovative Healthcare Ecosystem Benchmark to Drive High-Quality Regional Healthcare Development
Thanks to the continuous marketization, legalization, and internationalization of China's business environment, BD Medical’s operations in China have been expanding at an accelerated pace. Through substantial and ongoing investments, BD has cast a "vote of confidence" in the Chinese economy. As one of China’s major economic provinces, Zhejiang's level of internationalization is increasingly growing, with various industrial resources like biomedicine converging here. Hangzhou, the provincial capital, stands as a benchmark city for digital innovation in China. Recognizing the significant development opportunities for future localization and innovation ecosystem construction in Hangzhou, BD Medical ultimately chose to locate its Greater China Innovation Center in Gongshu District. The aim is to leverage Hangzhou to create a "radiating effect across eastern China and covering the entire country," while collaborating with local partners to build an innovative healthcare ecosystem. This initiative not only drives BD Medical’s sustainable growth but also empowers regional "high-quality development" and "high-standard construction."
At the opening ceremony,Sun Xudong, Vice Mayor of Hangzhou Municipal People's Government"We believe that the launch of BD Greater China Innovation Center will leverage the resource elements, spatial platforms, industrial clusters, and cultural heritage of Gongshu District in Hangzhou to harness BD's global innovation resources and explore a new blue ocean in the 'digital economy + life health' industry. We look forward to both parties working hand in hand for mutual benefit and win-win outcomes, jointly creating a golden ecosystem for the life health industry, contributing to the high-quality economic development of Hangzhou, and vigorously advancing the three 'No.1 Projects' of the provincial Party committee and government."
Li Zhilong, Secretary of the Gongshu District Committee of Hangzhou CityStated: "We sincerely look forward to BD Medical leveraging its deep industry expertise, making good use of Gongshu's innovative resources, strengthening localized industry-academia-research cooperation and local talent cultivation, and building an open medical innovation ecosystem to accumulate innovative momentum for the high-quality development of the medical device industry. We also sincerely hope that BD Medical will play a leading role in gathering resources, actively connecting with investment, industry, and other ecological partners, attracting more companies and partners within the industry ecosystem to establish themselves in Gongshu, bringing more outstanding experts and talents to settle in Gongshu, and creating an open, communicative, and mutually beneficial industrial ecosystem."
Chairman of the Global Board of Directors, BDCEOPresident兼CEO柏乐(Tom Polen)Stated: "As one of the largest and most innovative medical technology companies globally, BD leverages its influence and scale to actively address the most challenging issues in the healthcare field. Since entering China in 1994, BD has delivered hundreds of thousands of innovative products to meet the evolving needs of Chinese patients. China has always been a key strategic market for BD, and the establishment of the Greater China Innovation Center (GCIC) marks another milestone in our development in China. It also demonstrates our commitment to supporting the high-quality development of China's medical technology industry. With the opening of the Greater China Innovation Center, we have entered a new era of medical innovation. We will continue to focus on addressing the real challenges faced by China’s healthcare system and patients, contributing to the creation of a healthier society and the realization of Healthy China."

Tom Polen, Chairman of the Board, CEO and President of BD Medical
At the event, five clinical training centers under BD Medical held unveiling ceremonies, including:Vascular Access Skills Training Center, Hernia Surgery Specialty High-Quality Development Project Joint Promotion Training Base, BD Peripheral Intervention Professional Education Academy, Laboratory Capability Building Demonstration Training Center, and BD Urology Training CenterBD hopes to establish a professional clinical training center to provide standardized education and customized specialized courses for various disciplines, aiming to popularize concepts, master specialties, enhance skills, and train new and qualified practitioners. Meanwhile, it also aims to create more academic exchange opportunities for medical professionals in China, thereby strengthening the clinical treatment capabilities of hospitals and helping more patients regain their health.
An Important Part of BD's Collaborative Innovation Ecosystem --Innovation Incubation CenterAlso inaugurated on the same day was the Innovation Incubation Center, which is equipped with globally leading laboratory equipment and simulation environments, serving as an innovative space that integrates clinical and engineering expertise. As a key resource within BD's innovation ecosystem, the Innovation Incubation Center empowers BD’s partners, assisting clinical experts in transforming scientific research into practical applications. Additionally, leveraging the multidisciplinary training programs offered by the Training Center, it facilitates close interaction between clinical experts and engineering teams, enabling R&D teams to promptly and deeply understand clinical feedback. This enhances the efficiency and quality of product development, fosters more original innovative solutions, and ultimately better serves local market needs in China.
Accelerate Local Strategic Cooperation, Jointly Upgrade the Medical Ecosystem
BD not only vigorously promotes local innovation in China but also actively seeks strategic cooperation with local enterprises. During the event, two electronic signing ceremonies were held to achieve mutual benefits and win-win results in new fields.
CAREFUSION (SHANGHAI) COMMERCIAL AND TRADING COMPANY LIMITED, a subsidiary of BD, and Hangzhou Chunlai Technology Co., Ltd. have signedFramework Contract for Medicine Dispensing Machine CooperationBoth parties aim to meet local needs, focus on the "China Strategy," and are committed to serving the construction of smart hospitals and smart pharmacies in China through local innovation, local manufacturing, and close cooperation within the local ecosystem, with greater speed, a more relevant perspective, and more optimized approaches.
At the same time, BD Medical also entered into an agreement with Yabuli Holding Group regardingInnovative Catheter Products Strategic Cooperation ProjectThe signing has been completed. BD expects that through this project, the groundbreaking innovative female external catheter will be accelerated to introduce into China, allowing the achievements of global medical technology advancements to benefit local patients as soon as possible, and bring strong momentum for the sustainable development of its business in China.
Before the official opening of the Innovation Center,BD Biosciences Latest GenerationBD RhapsodyTM HT XpressUltra-Throughput Single-Cell PlatformHas already taken the lead in domestic strategic cooperation, welcoming the first batch of Chinese customer signing ceremonies. BD RhapsodyTMHT Xpress, as a single-cell multi-omics research platform with millions of cell throughput and epoch-making significance, made its first official face-to-face appearance with customers after its launch, and successfully closed orders for 6 units.。This signing also marksLatest Global OrderCell technology enters the practical stage in China, which will help accelerate and upgrade single-cell research in the country.
Moreover, after the opening of the Innovation Center, BD Medical also plans to launch "National Laboratory Capacity Building and Quality Management Improvement Project"Join hands with top testing experts in China, CAP American Society for Clinical Pathology, etc., to build a dedicated communication platform. By aligning with international cutting-edge standards and global academic resources, establish a Center of Excellence for laboratories to comprehensively enhance grassroots capabilities, strengthen the promotion and education of leading disciplines, drive capacity building in the field of laboratory medicine, and continuously optimize the quality management of laboratory specimens in China."
To benefit more patients through innovation and help achieve“Healthy China2030”
Innovation is in the DNA of BD Medical, and also the cornerstone of the medical industry ecosystem. BD Medical came to China in 1994 and has continuously increased its efforts to foster local innovation in China, establishing Shanghai as the center for innovative design and multifunctional laboratories, and Suzhou as the center for laboratory engineering."Dual Center Strategy for R&D"On the one hand, based on the market demands in China, optimize product functions and accelerate product implementation; on the other hand, also carry out local innovative development according to the needs of Chinese patients, which not only better meets local market demands but also benefits more patients. The opening of BD Medical’s Greater China Innovation Center is another major milestone for BD Medical following the "Dual R&D Center Strategy," and it also allows BD Medical to better "Rooted in China, Serving China;Based in China, Moving Towards the World",which reflects the continuous acceleration of localization innovation in China."
Mr. Deng Jianmin, Global Senior Vice President of BD and General Manager of Greater ChinaStated: "Under the support of national policies encouraging innovation, BD Medical’s Greater China Innovation Center will maximize its strengths. On one hand, BD Medical will increase innovation and R&D efforts to address unmet medical and research needs, creating innovative products that meet the clinical and research demands in China, accelerating the local implementation of these innovations in China, and benefiting a wide range of Chinese patients. On the other hand, as an important component in building local brand influence and fostering an ecosystem, the Greater China Innovation Center will serve as an interactive platform for BD Medical to engage with local 'industry-academia-research-medical' sectors. BD Medical will continue to take on the responsibility of an industry leader, promoting open innovation and transformation within the sector through localized innovation partnerships, and is committed to creating a collaborative and win-win industrial ecosystem."

Deng Jianmin, Global Senior Vice President of BD and General Manager of Greater China
The total construction area of the Greater China Innovation Center exceeds 3,400 square meters, encompassingCustomer Experience Center, Professional Training Center, Innovation Incubation CenterAndDigital Innovation CenterFour core sectors. Among them, it is particularly worth emphasizing that,Customer Experience CenterEncompassing three major live demonstration themes: innovative interventional ecosystems, precision oncology diagnosis and treatment, and future laboratories, it showcases BD's integrated innovative product solutions from cutting-edge research to clinical diagnosis and intelligent healthcare.Professional Training CenterEquipped with microbiology laboratories, dry/wet labs, conference rooms, and路演 halls, among others. The facilities for relevant experimental training and operational drills are complete. Moreover, through broadcasting equipment, the practical procedures in operating rooms or laboratories can be simultaneously broadcast to other classrooms on the same floor, enabling more efficient training coverage.
Relying on its professional training center, first-class digital and intelligent communication base, and efficient innovation incubation platform, the BD Greater China Innovation Center is expected to host more than 150 internal and external training sessions annually, covering over 15,000 customers, as well as over 2,000 dealers and employees each. In addition, the Innovation Center is also expected to host more than 15 government and think tank forums, providing an interactive communication platform for enterprises, local industry experts, government think tanks, industry peers, and university scholars.
By attracting more academic and market events of national and even global significance to be held here, and drawing in more high-quality partners to jointly explore new pathways and methods for medical innovation, BD will leverage its Greater China Innovation Center as a "fulcrum" to facilitate the efficient incubation of innovative achievements and the transformation and upgrading of regional economic industries, contributing to the "Healthy China 2030" initiative.